Safety and Preliminary Efficacy of OBT076 in Recurrent/Metastatic CD205+ Solid Tumors

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Safety and Preliminary Efficacy of OBT076 in Recurrent/Metastatic CD205+ Solid Tumors	Solid Tumor	Recruiting	Phase 1	2025-09-16		NCT04064359

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Oxford BioTherapeutics Ltd	1

27 results · Page 1 of 2

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
AZ Groeninge	Kortrijk	Belgium	18
Cedars-Sinai	Los Angeles	United States	16
Centre Eugène Marquis	Rennes	France	37
Columbia University Medical center	New York	United States	224
EuroMedica	Thessaloniki	Greece	1
GHP Saint-Joseph	Paris	France	1
Hopital Saint Antoine	Paris	France	8
Hopital Saint Louis	Paris	France	12
Hospital Universitario Fundacion Jimenez Diaz	Madrid	Spain	63
ICANS - Institut de Cancérologie Strasbourg	Strasbourg	France	2
Institut Gustave Roussy - IGR	Villejuif	France	1
Institut Jules Bordet	Brussels	Belgium	23
Institut Paoli Calmettes	Marseille	France	49
Mayo Clinic	Phoenix	United States	1
Metropolitan Hospital	Athens	Greece	3
Moffitt Cancer Center	Tampa	United States	523
Quantum Santa Fe	Santa Fe	United States	2
Sotiria General Hospital	Athens	Greece	1
St. Elizabeth Healthcare	Edgewood	United States	21
START Barcelona HM Nou Delfos	Barcelona	Spain	2
The State University of Iowa	Iowa City	United States	2
UCLA	Santa Monica	United States	14
University General Hospital Attikon	Chaïdári	Greece	1
University General Hospital of Heraklion	Heraklion	Greece	5
University Hospital Marqués de Valdecilla	Santander	Spain	1

Clinical trials